Literature DB >> 22921328

Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies.

Eric B Schneider1, Omar Hyder, Christopher L Wolfgang, Kenzo Hirose, Michael A Choti, Martin A Makary, Joseph M Herman, John L Cameron, Timothy M Pawlik.   

Abstract

BACKGROUND: The incidence and associated risk factors for readmission after hepato-pancreato-biliary surgery are poorly characterized. The objective of the current study was to compare readmission after pancreatic vs hepatobiliary surgical procedures, as well as to identify potential factors associated with higher readmission within 30 days of discharge. STUDY
DESIGN: Using Surveillance, Epidemiology and End Results-Medicare linked data from 1986-2005, we identified 9,957 individuals aged 66 years and older who underwent complex hepatic, biliary, or pancreatic procedures for cancer treatment and were eligible for analysis. In-hospital morbidity, mortality, and 30-day readmission were examined.
RESULTS: Primary surgical treatment consisted of a pancreatic (46.7%), hepatic (50.0%), or biliary (3.4%) procedure. Mean patient age was 72.6 years and most patients were male (53.2%). The number of patients with multiple preoperative comorbidities increased over time (patients with Elixhauser's comorbidity score >13: 1986-1990, 47.0% vs 2001-2005, 62.9%; p < 0.001). Pancreatic operations had higher inpatient mortality vs hepatobiliary procedures (9.2% vs 7.3%; p < 0.001). Mean length of stay after pancreatic procedures was longer compared with hepatobiliary procedures (19.7 vs 10.3 days; p < 0.001). The proportion of patients readmitted after a pancreatic (1986-1990, 17.7%; 1991-1995, 16.1%; 1996-2000, 18.6%; 2001-2005, 19.6%; p = 0.15) or hepatobiliary (1986-1990, 14.3%; 1991-1995, 14.1%; 1996-2000, 15.2%; 2001-2005, 15.5%; p = 0.69) procedure did not change over time. Factors associated with increased risk of readmission included preoperative Elixhauser comorbidities >13 (odds ratio = 1.90) and prolonged index hospital stay ≥10 days (odds ratio = 1.54; both p < 0.05). During the readmission, additional morbidity and mortality were 46.5% and 8.0%, respectively.
CONCLUSIONS: Although the incidence of readmission did not change across the time periods examined, readmission was higher among patients undergoing a pancreatic procedure vs a hepatobiliary procedure. Other factors associated with risk of readmission included number of patient comorbidities and prolonged hospital stay. Readmission was associated with additional short-term morbidity and mortality.
Copyright © 2012 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22921328      PMCID: PMC4051393          DOI: 10.1016/j.jamcollsurg.2012.07.007

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  23 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors.

Authors:  Eric B Schneider; Omar Hyder; Benjamin S Brooke; Jonathan Efron; John L Cameron; Barish H Edil; Richard D Schulick; Michael A Choti; Christopher L Wolfgang; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-01-29       Impact factor: 6.113

3.  Elective surgery for diverticulitis is associated with high risk of intestinal diversion and hospital readmission in older adults.

Authors:  Anne O Lidor; Eric Schneider; Jodi Segal; Qilu Yu; Richard Feinberg; Albert W Wu
Journal:  J Gastrointest Surg       Date:  2010-09-28       Impact factor: 3.452

4.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

5.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

6.  Readmissions after pancreatoduodenectomy.

Authors:  R C van Geenen; T M van Gulik; O R Busch; L T de Wit; H Obertop; D J Gouma
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

7.  Hospital characteristics associated with unplanned readmissions.

Authors:  M Z Ansari; B T Collopy; J L Booth
Journal:  Aust Health Rev       Date:  1995       Impact factor: 1.990

8.  Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy.

Authors:  G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

9.  National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis.

Authors:  Skye C Mayo; Andrew D Shore; Hari Nathan; Barish Edil; Christopher L Wolfgang; Kenzo Hirose; Joseph Herman; Richard D Schulick; Michael A Choti; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

10.  Readmission after pancreatectomy for pancreatic cancer in Medicare patients.

Authors:  Deepthi M Reddy; Courtney M Townsend; Yong-Fang Kuo; Jean L Freeman; James S Goodwin; Taylor S Riall
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

View more
  45 in total

1.  A validated, risk assessment tool for predicting readmission after open ventral hernia repair.

Authors:  P A Baltodano; Y Webb-Vargas; K C Soares; C W Hicks; C M Cooney; P Cornell; K K Burce; T M Pawlik; F E Eckhauser
Journal:  Hernia       Date:  2015-08-19       Impact factor: 4.739

2.  Assessing readmission after general, vascular, and thoracic surgery using ACS-NSQIP.

Authors:  Donald J Lucas; Adil Haider; Elliot Haut; Rebecca Dodson; Christopher L Wolfgang; Nita Ahuja; John Sweeney; Timothy M Pawlik
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

3.  Early oral feeding after pancreatoduodenectomy enhances recovery without increasing morbidity.

Authors:  Arja Gerritsen; Roos A W Wennink; Marc G H Besselink; Hjalmar C van Santvoort; Dorine S J Tseng; Elles Steenhagen; Inne H M Borel Rinkes; I Quintus Molenaar
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

4.  Readmission After Liver Resection for Intrahepatic Cholangiocarcinoma: a Multi-Institutional Analysis.

Authors:  Gaya Spolverato; Hadia Maqsood; Alessandro Vitale; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; Carlo Pulitano; Todd W Bauer; Feng Shen; George Poultsides; Shishir Maithel; J Wallis Marsh; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-04-23       Impact factor: 3.452

5.  Thirty days are inadequate for assessing readmission following complex hepatopancreatobiliary procedures.

Authors:  Maria S Altieri; Jie Yang; Donglei Yin; Konstantinos Spaniolas; Mark Talamini; Aurora Pryor
Journal:  Surg Endosc       Date:  2018-12-10       Impact factor: 4.584

6.  Unplanned 30-Day Readmissions in a General Internal Medicine Hospitalist Service at a Comprehensive Cancer Center.

Authors:  Joanna-Grace M Manzano; Sahitya Gadiraju; Adarsh Hiremath; Heather Yan Lin; Jeff Farroni; Josiah Halm
Journal:  J Oncol Pract       Date:  2015-07-07       Impact factor: 3.840

7.  Specific Medicare Severity-Diagnosis Related Group Codes Increase the Predictability of 30-Day Unplanned Hospital Readmission After Pancreaticoduodenectomy.

Authors:  Dimitrios Xourafas; Katiuscha Merath; Gaya Spolverato; Stanley W Ashley; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

8.  Trends and risk factors for transfusion in hepatopancreatobiliary surgery.

Authors:  Donald J Lucas; Katherine I Schexneider; Matthew Weiss; Christopher L Wolfgang; Steven M Frank; Kenzo Hirose; Nita Ahuja; Martin Makary; John L Cameron; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-12-10       Impact factor: 3.452

9.  Investigating Transitional Care to Decrease Post-pancreatectomy 30-Day Hospital Readmissions for Dehydration or Failure to Thrive.

Authors:  Dimitrios Xourafas; Akweley Ablorh; Thomas E Clancy; Richard S Swanson; Stanley W Ashley
Journal:  J Gastrointest Surg       Date:  2016-03-08       Impact factor: 3.452

10.  Incidence and Risk Factors Associated with Readmission After Surgical Treatment for Adrenocortical Carcinoma.

Authors:  Javier Valero-Elizondo; Yuhree Kim; Jason D Prescott; Georgios A Margonis; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-08-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.